Speaking at the 29th meeting of Stop TB Partnership coordination committee, Union Health Minister J P Nadda said that India has formulated a national strategic plan with a special focus on stamping out the bactrial disease at grassroot levels.
"We have implemented daily drug regimen for treating tuberculosis (TB) in five states and by the year end it will be rolled out in the entire country," Nadda said.
The new regimen helps in reducing relapse rates and number of drug-resistant TB cases.
The CBNAAT is a revolutionary rapid molecular test which detects Mycobacterium tuberculosis and rifampicin drug resistance, simultaneously.
He further said that the government will frame special programmes to combat multidrug-resistant TB.
Later, in a tweet, the Minister said the he met the Netherlands' State Secretary in the Ministry of Health, to discuss possibilities of cooperation in Antimicrobial resistance (AMR).
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
